NNVC - NanoViricides, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc.

NNVC 1.685

-0.9%

Oct 31 3:55 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: donpat	6/1/2015 9:57:07 PM
	3 Recommendations Recommended By drkaz Magnus1 Savant Read Replies (1) of 12871

status of drug testing results eugeneseymourmd@mac.com donpatent June 1, 2015, 9:47 PM FluCide Phase I and II of tox successfully completed Making material for last Phase in large animals MersCide Waiting for Public Health England to request the drug (sitting on the shelf) for testing. They got distracted by the Ebola outbreak EbolaCide Making more drug for continuation of the testing by USAMRIID Had FluCide not turned out to be so incredibly safe, we would have been done with tox by now. Incredibly safe is not a bad thing at all! Eugene Seymour MD MPH Chief Executive Officer NanoViricides, Inc eugene@nanoviricides.com www.nanoviricides.com 310-486-5677 "NNVC" on the New York Stock Exchange

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next